FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 26436-5632 | 26436-5632-5 | CCDB | Ciprofloxacin 40.7% Clotrimazole 40.7% Dexamethasone 3.4% Boric acid 15.2% | 407 mg/1 g; 34 mg/1 g; 407 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5526 | 26436-5526-0 | Combo Drops | Cyclopentaloate 2%, Phenyephrine 2.5%, Tropicamide 0.5% | 25 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5579 | 26436-5579-1 | Diclofenac sodium | Diclofenac sodium 100mg | 100 mg | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5628 | 26436-5628-3 | DILTIAZEM 2% | DILTIAZEM 2% | 20 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5091 | 26436-5091-5 | DMSO 50% | DMSO 50% | 30 [PNU]/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5150 | 26436-5150-1 | Doxycycline Hyclate 0.025% | doxycycline Hyclate 0.025% | .25 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5619 | 26436-5619-3 | Estradiol 1mg/gm | Estradiol 1mg/gm | 1 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5343 | 26436-5343-1 | Estriol | Estriol | 2 mg | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-0732 | 26436-0732-1 | Estriol | Estriol | 2 mg | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5465 | 26436-5465-3 | Estriol 10mg DHEA10mg/gm | Estriol 10mg DHEA10mg/gm | 10 mg/1 g; 10 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5325 | 26436-5325-1 | Estriol 1mg DHEA10mg/gm | Estriol 1mg DHEA10mg/gm | 1 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5101 | 26436-5101-3 | Glutamine 25mg/mL | Glutamine 25mg/mL | 25 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5593 | 26436-5593-3 | Glutamine Arginine HCl Carnitine 25/100/100mg/mL | Glutamine (L), Arginine HCl, Carnitine (L) | 100 mg/1 mL; 100 mg/1 mL; 25 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5028 | 26436-5028-3 | Glutathione | Glutathione | 100 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5227 | 26436-5227-3 | Glycine 100mg/mL | Glycine 100mg/mL | 100 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5169 | 26436-5169-3 | Isoleucine/Leucine/Valine (BCAA) 15/10/40mg/mL | Isoleucine/Leucine/Valine | 15 mg/1 mL; 40 mg/1 mL; 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5311 | 26436-5311-1 | LET Topical Gel | LET Topical Gel | .5 mg/1 mL; 5 mg/1 mL; 40 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5480 | 26436-5480-1 | Lidocaine 1% PF | Lidocaine 1% PF | 10 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5324 | 26436-5324-1 | LIDOCAINE/TETRACAINE 23%/7% | LIDOCAINE TETRACAINE 23%/7% | 70 mg/1 g; 230 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5624 | 26436-5624-1 | LIDOCAINE/TETRACAINE/ PHENYLEPHRINE HCL 20%/7%/0.5% | LIDOCAINE/TETRACAINE/ PHENYLEPHRINE HCL 20/7/0.5 | 70 mg/1 g; 200 mg/1 g; 5 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5638 | 26436-5638-1 | LIDOCAINE/TETRACAINE/ PHENYLEPHRINE HCL 23%/7%/0.5% | LIDOCAINE/TETRACAINE/ PHENYLEPHRINE HCL 23/7/0.5 | 70 mg/1 g; 230 mg/1 g; 5 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5080 | 26436-5080-3 | Lysine 100mg/mL | Lysine Hydrochloride 100mg/mL | 100 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5596 | 26436-5596-3 | m-B12 MIC | Methylcobalamin Methionine Inositol Choline Chloride | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5596 | 26436-5596-1 | m-B12 MIC | Methylcobalamin Methionine Inositol Choline Chloride | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5015 | 26436-5015-3 | Methylcobalamin | Methylcobalamin | 1 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5354 | 26436-5354-1 | Methylene Blue 5mg/mL | Methylene Blue 5mg/mL | 5 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5595 | 26436-5595-3 | MIC | Methionine Inositol Choline chloride | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5558 | 26436-5558-0 | NAD | NICOTINAMIDE ADENINE DINUCLEOTIDE 50mg | 50 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5642 | 26436-5642-1 | NAD | NICOTINAMIDE ADENINE DINUCLEOTIDE 50mg | 50 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5558 | 26436-5558-5 | NAD | NICOTINAMIDE ADENINE DINUCLEOTIDE 50mg | 50 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5629 | 26436-5629-1 | Naltrexone HCL 2mg | Naltrexone HCL 2mg | 2 mg | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5066 | 26436-5066-3 | Niacinamide 100mg/mL | Niacinamide 100mg/mL | 100 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5007 | 26436-5007-3 | Panthenol 250mg/mL | Panthenol 250mg/mL | 250 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5580 | 26436-5580-1 | Phenol | Phenol | 50 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-6001 | 26436-6001-1 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | .2 meq/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5044 | 26436-5044-3 | Procaine 2% | Procaine 2% | 20 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5248 | 26436-5248-1 | Progesterone 125mg | Progesterone 125mg | 125 mg | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5152 | 26436-5152-1 | Progesterone 150mg | Progesterone 150mg | 150 mg | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5183 | 26436-5183-5 | Quadmix 60/30/3/0.03 | Quadmix 60/30/3/0.03 | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5635 | 26436-5635-2 | SEMAGLUTIDE | SEMAGLUTIDE | 5 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5608 | 26436-5608-2 | SEMAGLUTIDE | SEMAGLUTIDE | 2.5 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5640 | 26436-5640-1 | Sermorelin acetate 300mcg | Sermorelin acetate 300 mcg | 300 ug | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5424 | 26436-5424-1 | Sermorelin acetate 300mcg | Sermorelin acetate 300 mcg | 300 ug | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5424 | 26436-5424-2 | Sermorelin acetate 300mcg | Sermorelin acetate 300 mcg | 300 ug | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5613 | 26436-5613-1 | TADALAFIL | TADALAFIL | 12 mg | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5024 | 26436-5024-3 | Taurine 50mg/mL | Taurine 50mg/mL | 50 mg/1 mL | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5616 | 26436-5616-3 | TESTOSTERONE | TESTOSTERONE | 1 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5244 | 26436-5244-5 | TESTOSTERONE 15% | TESTOSTERONE 15 | 150 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5161 | 26436-5161-1 | TESTOSTERONE 1MG | TESTOSTERONE 1MG | 1 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 26436-5605 | 26436-5605-3 | TESTOSTERONE 20% | TESTOSTERONE 20% | 200 mg/1 g | 2025-1 | valid | 2026-09-18 |